Breast Lesion Localization Methods Market Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027
Breast Lesion Localization Methods Market
Breast cells multiply out of
control, leading to a lump that may or may not be cancerous in nature. This
condition is known as breast cancer. These cells typically develop tumours,
which are frequently visible on x-rays or palpable as lumps. The breast lesion
localization methods market is anticipated to grow as a result of rising breast
cancer prevalence, rising treatment awareness, favourable reimbursement
policies in developed and emerging economies, and rising product development. Breast
lesion localization methods market growth is anticipated to be driven by rising
breast cancer prevalence in developed and developing economies over the course
of the forecast period.
Additionally, the breast
lesion localization methods market is anticipated to grow in the near
future due to the ongoing population growth in emerging economies like India and
the growing emphasis on improving the healthcare infrastructure in developing
economies. For instance, according to The Pink Initiative and Breast Cancer
Statistics in India, breast cancer accounts for 25% to 32% of all female
cancers and is the most common cancer in most Indian cities and the second most
common in rural areas.
However, the Breast
Lesion Localization Methods market's major players
are concentrating on creating new products to broaden their product lines,
which is anticipated to fuel market expansion over the coming years. For
instance, the radiofrequency identification (RFID) breast lesion localization
device from Hologic Inc. received FDA approval in January 2019 for long-term
use.
Comments
Post a Comment